Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
22.88
-0.35 (-1.51%)
At close: Mar 13, 2026, 4:00 PM EDT
22.26
-0.62 (-2.71%)
After-hours: Mar 13, 2026, 4:17 PM EDT
Zymeworks Revenue
In the year 2025, Zymeworks had annual revenue of $105.97M with 38.87% growth. Zymeworks had revenue of $2.52M in the quarter ending December 31, 2025, a decrease of -91.90%.
Revenue (ttm)
$105.97M
Revenue Growth
+38.87%
P/S Ratio
15.92
Revenue / Employee
$401,383
Employees
264
Market Cap
1.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 105.97M | 29.66M | 38.87% |
| Dec 31, 2024 | 76.30M | 292.00K | 0.38% |
| Dec 31, 2023 | 76.01M | -336.47M | -81.57% |
| Dec 31, 2022 | 412.48M | 385.80M | 1,446.03% |
| Dec 31, 2021 | 26.68M | -12.27M | -31.50% |
| Dec 31, 2020 | 38.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sarepta Therapeutics | 2.20B |
| Novavax | 1.12B |
| Iovance Biotherapeutics | 263.50M |
| AnaptysBio | 234.60M |
| Recursion Pharmaceuticals | 74.68M |
| Generate Biomedicines | 31.89M |
| Capricor Therapeutics | 11.13M |
ZYME News
- 10 days ago - Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside - Seeking Alpha
- 12 days ago - Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing - GlobeNewsWire
- 12 days ago - Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026 - GlobeNewsWire
- 6 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Zymeworks Inc. (ZYME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy - GlobeNewsWire